BACKGROUND: Hepatocyte nuclear factor-1 beta (HNF-1beta) is a widely distributed transcription factor which plays a critical role in embryonic development of the kidney, pancreas, liver, and Mullerian duct. Thirty HNF-1beta mutations have been reported in patients with renal cysts and other renal developmental disorders, young-onset diabetes, pancreatic atrophy, abnormal liver function tests, and genital tract abnormalities. METHODS: We sequenced the HNF-1beta gene in 160 unrelated subjects with renal disease, 40% of whom had a personal/family history of diabetes. RESULTS: Twenty three different heterozygous HNF-1beta mutations were identified in 23/160 subjects (14%), including 10 novel mutations (V61G, V110G, S148L, K156E, Q176X, R276Q, S281fsinsC, R295P, H324fsdelCA, Q470X). Seven (30%) cases were proven to be due to de novo mutations. Renal cysts were found in 19/23 (83%) patients (four with glomerulocystic kidney disease, GCKD) and diabetes in 11/23 (48%, while three other families had a family history of diabetes. Only 26% of families met diagnostic criteria for maturity-onset diabetes of the young (MODY) but 39% had renal cysts and diabetes (RCAD). We found no clear genotype/phenotype relationships. CONCLUSION: We report the largest series to date of HNF-1beta mutations and confirm HNF-1beta mutations as an important cause of renal disease. Despite the original description of HNF-1beta as a MODY gene, a personal/family history of diabetes is often absent and the most common clinical manifestation is renal cysts. Molecular genetic testing for HNF-1beta mutations should be considered in patients with unexplained renal cysts (including GCKD), especially when associated with diabetes, early-onset gout, or uterine abnormalities.
BACKGROUND:Hepatocyte nuclear factor-1 beta (HNF-1beta) is a widely distributed transcription factor which plays a critical role in embryonic development of the kidney, pancreas, liver, and Mullerian duct. Thirty HNF-1beta mutations have been reported in patients with renal cysts and other renal developmental disorders, young-onset diabetes, pancreatic atrophy, abnormal liver function tests, and genital tract abnormalities. METHODS: We sequenced the HNF-1beta gene in 160 unrelated subjects with renal disease, 40% of whom had a personal/family history of diabetes. RESULTS: Twenty three different heterozygous HNF-1beta mutations were identified in 23/160 subjects (14%), including 10 novel mutations (V61G, V110G, S148L, K156E, Q176X, R276Q, S281fsinsC, R295P, H324fsdelCA, Q470X). Seven (30%) cases were proven to be due to de novo mutations. Renal cysts were found in 19/23 (83%) patients (four with glomerulocystic kidney disease, GCKD) and diabetes in 11/23 (48%, while three other families had a family history of diabetes. Only 26% of families met diagnostic criteria for maturity-onset diabetes of the young (MODY) but 39% had renal cysts and diabetes (RCAD). We found no clear genotype/phenotype relationships. CONCLUSION: We report the largest series to date of HNF-1beta mutations and confirm HNF-1beta mutations as an important cause of renal disease. Despite the original description of HNF-1beta as a MODY gene, a personal/family history of diabetes is often absent and the most common clinical manifestation is renal cysts. Molecular genetic testing for HNF-1beta mutations should be considered in patients with unexplained renal cysts (including GCKD), especially when associated with diabetes, early-onset gout, or uterine abnormalities.
Authors: F Beards; T Frayling; M Bulman; Y Horikawa; L Allen; M Appleton; G I Bell; S Ellard; A T Hattersley Journal: Diabetes Date: 1998-07 Impact factor: 9.461
Authors: H Nishigori; S Yamada; T Kohama; H Tomura; K Sho; Y Horikawa; G I Bell; T Takeuchi; J Takeda Journal: Diabetes Date: 1998-08 Impact factor: 9.461
Authors: Y Horikawa; N Iwasaki; M Hara; H Furuta; Y Hinokio; B N Cockburn; T Lindner; K Yamagata; M Ogata; O Tomonaga; H Kuroki; T Kasahara; Y Iwamoto; G I Bell Journal: Nat Genet Date: 1997-12 Impact factor: 38.330
Authors: K Yamagata; N Oda; P J Kaisaki; S Menzel; H Furuta; M Vaxillaire; L Southam; R D Cox; G M Lathrop; V V Boriraj; X Chen; N J Cox; Y Oda; H Yano; M M Le Beau; S Yamada; H Nishigori; J Takeda; S S Fajans; A T Hattersley; N Iwasaki; T Hansen; O Pedersen; K S Polonsky; G I Bell Journal: Nature Date: 1996-12-05 Impact factor: 49.962
Authors: Li Wang; Catherine Coffinier; Melissa K Thomas; Lionel Gresh; Ganiu Eddu; Tal Manor; Lynne L Levitsky; Moshe Yaniv; David B Rhoads Journal: Endocrinology Date: 2004-05-13 Impact factor: 4.736
Authors: E A Andersson; K Pilgaard; C Pisinger; M N Harder; N Grarup; K Faerch; P Poulsen; D R Witte; T Jørgensen; A Vaag; T Hansen; O Pedersen Journal: Diabetologia Date: 2010-05-20 Impact factor: 10.122
Authors: Silvia Ferrè; Jeroen H F de Baaij; Patrick Ferreira; Roger Germann; Johannis B C de Klerk; Marla Lavrijsen; Femke van Zeeland; Hanka Venselaar; Leo A J Kluijtmans; Joost G J Hoenderop; René J M Bindels Journal: J Am Soc Nephrol Date: 2013-11-07 Impact factor: 10.121
Authors: Dagan Jenkins; Maria Bitner-Glindzicz; Louise Thomasson; Sue Malcolm; Stephanie A Warne; Sally A Feather; Sarah E Flanagan; Sian Ellard; Coralie Bingham; Lane Santos; Mark Henkemeyer; Andrew Zinn; Linda A Baker; Duncan T Wilcox; Adrian S Woolf Journal: J Pediatr Urol Date: 2007-02 Impact factor: 1.830